Supplemental material
Future Oncology
Volume 19, 2023 - Issue 14
Open access
1,112
Views
0
CrossRef citations to date
0
Altmetric
Short Communication
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study
Mutlu Arat1 Demiroglu Bilim University, Istanbul Florence Nightingale Hospital,
Istanbul,
TurkeyCorrespondence[email protected]
https://orcid.org/0000-0003-2039-8557View further author information
Inci Alacacioglu2 Department of Internal Medicine, Dokuz Eylül University Medical Faculty Hospital,Division of Hematology,
Izmir, Turkey
https://orcid.org/0000-0002-8187-7159View further author information
Ali Zahit Bolaman3 Department of Internal Medicine, Aydin Adnan Menderes University Faculty of Medicine,Division of Hematology,
Aydin, Turkey
https://orcid.org/0000-0003-0651-5462View further author information
Yahya Buyukasik4 Department of Internal Medicine, Hacettepe University Faculty of Medicine,Division of Hematology,
Ankara, Turkey
https://orcid.org/0000-0002-4764-2348View further author information
Seckin Cagirgan5 Division of Hematology, Medicalpoint Izmir Hospital,
Izmir, Turkey
https://orcid.org/0000-0002-7579-5624View further author information
Birol Güvenc6 Department of Internal Medicine, Cukurova University Medical Faculty Hospital,Division of Hematology,
Adana, Turkey
https://orcid.org/0000-0001-7641-5673View further author information
Emin Kaya7 Department of Internal Medicine, Inönü University Faculty of Medicine,Division of Hematology,
Malatya, Turkey
https://orcid.org/0000-0001-8605-8497View further author information
Mehmet Ali Ozcan2 Department of Internal Medicine, Dokuz Eylül University Medical Faculty Hospital,Division of Hematology,
Izmir, Turkey
https://orcid.org/0000-0002-0096-5908View further author information
Ozan Salim8 Department of Internal Medicine, Akdeniz University Medical Faculty Hospital,Division of Hematology Antalya, Turkey
https://orcid.org/0000-0001-6687-0189View further author information
Filiz Vural9 Department of Internal Medicine, Ege University Medical Faculty Hospital,Division of Hematology,
Izmir, Turkey
https://orcid.org/0000-0003-3489-296XView further author information
Mehmet Yilmaz10 Department of Internal Medicine, SANKO University Faculty of Medicine,Division of Hematology,
Gaziantep, Turkey
https://orcid.org/0000-0002-1218-8165View further author information
Meltem Kurt Yüksel11 Department of Internal Medicine, Ankara University Medical Faculty Hospital,Division of Hematology,
Ankara, Turkey
https://orcid.org/0000-0003-0369-299XView further author information
Sirac Bozkurt12 Pfizer Pharmaceuticals,
Istanbul, Turkey
https://orcid.org/0000-0003-4053-8174View further author information
Birkan Aver12 Pfizer Pharmaceuticals,
Istanbul, Turkey
https://orcid.org/0000-0002-8650-6883View further author information
Rüstü Kaya12 Pfizer Pharmaceuticals,
Istanbul, Turkey
https://orcid.org/0000-0002-5302-7480View further author information
Osman Ilhan11 Department of Internal Medicine, Ankara University Medical Faculty Hospital,Division of Hematology,
Ankara, Turkey
https://orcid.org/0000-0003-1665-372XView further author information
Pages 975-982
|
Received 04 Oct 2022, Accepted 21 Apr 2023, Published online: 09 Jun 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.